These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15914230)

  • 1. Human APOBEC3G incorporation into murine leukemia virus particles.
    Kremer M; Bittner A; Schnierle BS
    Virology; 2005 Jun; 337(1):175-82. PubMed ID: 15914230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles.
    Douaisi M; Dussart S; Courcoul M; Bessou G; Vigne R; Decroly E
    Biochem Biophys Res Commun; 2004 Aug; 321(3):566-73. PubMed ID: 15358144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.
    Luo K; Liu B; Xiao Z; Yu Y; Yu X; Gorelick R; Yu XF
    J Virol; 2004 Nov; 78(21):11841-52. PubMed ID: 15479826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
    Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK
    J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3G incorporation into human immunodeficiency virus type 1 particles.
    Zennou V; Perez-Caballero D; Göttlinger H; Bieniasz PD
    J Virol; 2004 Nov; 78(21):12058-61. PubMed ID: 15479846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor.
    Schäfer A; Bogerd HP; Cullen BR
    Virology; 2004 Oct; 328(2):163-8. PubMed ID: 15464836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between HIV-1 Gag and APOBEC3G.
    Cen S; Guo F; Niu M; Saadatmand J; Deflassieux J; Kleiman L
    J Biol Chem; 2004 Aug; 279(32):33177-84. PubMed ID: 15159405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker.
    Burnett A; Spearman P
    J Virol; 2007 May; 81(10):5000-13. PubMed ID: 17344295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary function of the two catalytic domains of APOBEC3G.
    Navarro F; Bollman B; Chen H; König R; Yu Q; Chiles K; Landau NR
    Virology; 2005 Mar; 333(2):374-86. PubMed ID: 15721369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC3G targets specific virus species.
    Kobayashi M; Takaori-Kondo A; Shindo K; Abudu A; Fukunaga K; Uchiyama T
    J Virol; 2004 Aug; 78(15):8238-44. PubMed ID: 15254195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC3G ubiquitination by Nedd4-1 favors its packaging into HIV-1 particles.
    Dussart S; Douaisi M; Courcoul M; Bessou G; Vigne R; Decroly E
    J Mol Biol; 2005 Jan; 345(3):547-58. PubMed ID: 15581898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
    Langlois MA; Beale RC; Conticello SG; Neuberger MS
    Nucleic Acids Res; 2005; 33(6):1913-23. PubMed ID: 15809227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein.
    Alce TM; Popik W
    J Biol Chem; 2004 Aug; 279(33):34083-6. PubMed ID: 15215254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
    Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
    Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3G targets human T-cell leukemia virus type 1.
    Sasada A; Takaori-Kondo A; Shirakawa K; Kobayashi M; Abudu A; Hishizawa M; Imada K; Tanaka Y; Uchiyama T
    Retrovirology; 2005 May; 2():32. PubMed ID: 15943885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid.
    Derse D; Hill SA; Princler G; Lloyd P; Heidecker G
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2915-20. PubMed ID: 17299050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA.
    Certo JL; Kabdulov TO; Paulson ML; Anderson JA; Hu WS
    J Virol; 1999 Nov; 73(11):9170-7. PubMed ID: 10516024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.
    Russell RA; Wiegand HL; Moore MD; Schäfer A; McClure MO; Cullen BR
    J Virol; 2005 Jul; 79(14):8724-31. PubMed ID: 15994766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes.
    Khan MA; Kao S; Miyagi E; Takeuchi H; Goila-Gaur R; Opi S; Gipson CL; Parslow TG; Ly H; Strebel K
    J Virol; 2005 May; 79(9):5870-4. PubMed ID: 15827203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.